-
XLV
-
$175.29
-
+0.34%
-
$174.70
-
$175.82
-
$174.04
Prices as of 2026-08-25 16:20:51 ET
Ticker Appearances
Signal From Noise
The AI Play in Pharmaceuticals
After the past few years of AI hype and capital expenditure, investor attention is increasingly on concrete, real-world benefits of this new technology – both...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Broadening Accelerates as Health Care Services and Aerospace & Defense Break Out
NEAR-TERM US EQUITY TRENDS REMAIN BULLISH, AND WHILE TECHNOLOGY AND HEALTH CARE LED THURSDAY'S SESSION AS DEFENSIVE GROUPS AND FINANCIALS LAGGED, THERE HAS BEEN NO...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
First to Market
Credit Where It's Due?
CHART OF THE DAY GOOD MORNING! HSBC HSBC 0.28% shares slid 3.1% in U.S. trading yesterday after the bank disclosed a $400 million fraud exposure, linked...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
GOOGL & Memory Stock breakdown likely a short-term headwind for Technology
NOTE: As part of our transition from FS Insight to Fundstrat Direct, my daily notes will transition from mark. newton@fsinsight. com to mark. newton@fundstratdirect. com....
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2026
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
An encouraging rebound but the real test is early next week
NEAR-TERM US EQUITY TRENDS ARE BULLISH, AND SPX AND QQQ SEEM TO HAVE MADE AN IMPRESSIVE BOTTOM NEAR THE LOWS OF THEIR RESPECTIVE TREND CHANNELS,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
DJIA joins SPX, QQQ back at new all-time highs
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT IT’S THOUGHT THAT THE RALLY IN US STOCKS LIKELY WILL FACE SOME MEANINGFUL RESISTANCE...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - June 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Signal From Noise
The AI Play in Pharmaceuticals
After the past few years of AI hype and capital expenditure, investor attention is increasingly on concrete, real-world benefits of this new technology – both...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Broadening Accelerates as Health Care Services and Aerospace & Defense Break Out
NEAR-TERM US EQUITY TRENDS REMAIN BULLISH, AND WHILE TECHNOLOGY AND HEALTH CARE LED THURSDAY'S SESSION AS DEFENSIVE GROUPS AND FINANCIALS LAGGED, THERE HAS BEEN NO...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
First to Market
Credit Where It's Due?
CHART OF THE DAY GOOD MORNING! HSBC HSBC 0.28% shares slid 3.1% in U.S. trading yesterday after the bank disclosed a $400 million fraud exposure, linked...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
GOOGL & Memory Stock breakdown likely a short-term headwind for Technology
NOTE: As part of our transition from FS Insight to Fundstrat Direct, my daily notes will transition from mark. newton@fsinsight. com to mark. newton@fundstratdirect. com....
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2026
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
An encouraging rebound but the real test is early next week
NEAR-TERM US EQUITY TRENDS ARE BULLISH, AND SPX AND QQQ SEEM TO HAVE MADE AN IMPRESSIVE BOTTOM NEAR THE LOWS OF THEIR RESPECTIVE TREND CHANNELS,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
DJIA joins SPX, QQQ back at new all-time highs
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT IT’S THOUGHT THAT THE RALLY IN US STOCKS LIKELY WILL FACE SOME MEANINGFUL RESISTANCE...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - June 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Broadening Accelerates as Health Care Services and Aerospace & Defense Break Out
NEAR-TERM US EQUITY TRENDS REMAIN BULLISH, AND WHILE TECHNOLOGY AND HEALTH CARE LED THURSDAY'S SESSION AS DEFENSIVE GROUPS AND FINANCIALS LAGGED, THERE HAS BEEN NO...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
GOOGL & Memory Stock breakdown likely a short-term headwind for Technology
NOTE: As part of our transition from FS Insight to Fundstrat Direct, my daily notes will transition from mark. newton@fsinsight. com to mark. newton@fundstratdirect. com....
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2026
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
An encouraging rebound but the real test is early next week
NEAR-TERM US EQUITY TRENDS ARE BULLISH, AND SPX AND QQQ SEEM TO HAVE MADE AN IMPRESSIVE BOTTOM NEAR THE LOWS OF THEIR RESPECTIVE TREND CHANNELS,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
DJIA joins SPX, QQQ back at new all-time highs
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT IT’S THOUGHT THAT THE RALLY IN US STOCKS LIKELY WILL FACE SOME MEANINGFUL RESISTANCE...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotech breakout helps to fuel Healthcare outperformance
SHORT-TERM TRENDS REMAIN BULLISH, AND DAILY MOMENTUM GAUGES HAVE HIT OVERBOUGHT LEVELS WHILE DEMARK EXHAUSTION COULD MATERIALIZE USING MULTIPLE METHODS WITHIN THE NEXT FEW DAYS...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - June 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
What to watch for now to think a reversal might be coming
SHORT-TERM TRENDS IN US EQUITIES REMAIN BULLISH, AND SPX HAS NOW TURNED POSITIVE FOR THE YEAR AFTER HAVING RISEN OVER 1000 POINTS OFF THE 4/7/25...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
